Correct, I was asleep! But I did watch the MOA discussion from the ODAC meeting this morning. The MSB response reiterated that they clearly believe this therapy is not just a treatment for SR-aGVHD, but a treatment for a wide range of diseases involving systemic inflammation.
My point is that whether the MOA is, in fact, generalisable to other clinical applications beyond SR-aGVHD will have to be borne out in further clinical trials involving the treatment of other diseases. MSB have me convinced, and I desperately hope the results of future clinical trials for other applications (incl. for C-19-related ARDS) continue to support the theorised MOA!
- Forums
- ASX - By Stock
- MSB
- MSB Trading 2020 - a new dawn
MSB Trading 2020 - a new dawn, page-559
-
- There are more pages in this discussion • 12,512 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
92.5¢ |
Change
-0.020(2.12%) |
Mkt cap ! $1.056B |
Open | High | Low | Value | Volume |
93.0¢ | 93.5¢ | 92.0¢ | $2.103M | 2.270M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 106422 | 92.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
93.0¢ | 59027 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 106422 | 0.925 |
19 | 158666 | 0.920 |
11 | 152313 | 0.915 |
9 | 187310 | 0.910 |
5 | 56641 | 0.905 |
Price($) | Vol. | No. |
---|---|---|
0.930 | 59027 | 3 |
0.935 | 71301 | 3 |
0.940 | 42740 | 5 |
0.945 | 71253 | 4 |
0.950 | 55201 | 6 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |